HEADER AMINOTRANSFERASE 14-AUG-98 1BQD TITLE ASPARTATE AMINOTRANSFERASE P138A/P195A DOUBLE MUTANT COMPND MOL_ID: 1; COMPND 2 MOLECULE: ASPARTATE AMINOTRANSFERASE; COMPND 3 CHAIN: A, B; COMPND 4 SYNONYM: ASPARTATE TRANSAMINASE; COMPND 5 EC: 2.6.1.1; COMPND 6 ENGINEERED: YES; COMPND 7 MUTATION: YES; COMPND 8 OTHER_DETAILS: SCHIFF BASE BETWEEN LYS 258 AND COFACTOR, PYRIDOXAL- COMPND 9 5'-PHOSPHATE (PLP) SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: ESCHERICHIA COLI; SOURCE 3 ORGANISM_TAXID: 562; SOURCE 4 STRAIN: TY103; SOURCE 5 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 6 EXPRESSION_SYSTEM_TAXID: 562; SOURCE 7 EXPRESSION_SYSTEM_PLASMID: PKDHE19 KEYWDS TRANSFERASE, AMINOTRANSFERASE EXPDTA X-RAY DIFFRACTION AUTHOR V.N.MALASHKEVICH,J.N.JANSONIUS REVDAT 3 03-NOV-21 1BQD 1 REMARK SEQADV LINK REVDAT 2 24-FEB-09 1BQD 1 VERSN REVDAT 1 11-MAY-99 1BQD 0 JRNL AUTH L.BIROLO,V.N.MALASHKEVICH,G.CAPITANI,F.DE LUCA,A.MORETTA, JRNL AUTH 2 J.N.JANSONIUS,G.MARINO JRNL TITL FUNCTIONAL AND STRUCTURAL ANALYSIS OF CIS-PROLINE MUTANTS OF JRNL TITL 2 ESCHERICHIA COLI ASPARTATE AMINOTRANSFERASE. JRNL REF BIOCHEMISTRY V. 38 905 1999 JRNL REFN ISSN 0006-2960 JRNL PMID 9893985 JRNL DOI 10.1021/BI981467D REMARK 2 REMARK 2 RESOLUTION. 2.10 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : TNT 5D REMARK 3 AUTHORS : TRONRUD,TEN EYCK,MATTHEWS REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.10 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 20.00 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 COMPLETENESS FOR RANGE (%) : 92.1 REMARK 3 NUMBER OF REFLECTIONS : 58133 REMARK 3 REMARK 3 USING DATA ABOVE SIGMA CUTOFF. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : EVERY 10TH REFLECTION REMARK 3 R VALUE (WORKING + TEST SET) : 0.205 REMARK 3 R VALUE (WORKING SET) : 0.204 REMARK 3 FREE R VALUE : 0.240 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 10.100 REMARK 3 FREE R VALUE TEST SET COUNT : 6010 REMARK 3 REMARK 3 USING ALL DATA, NO SIGMA CUTOFF. REMARK 3 R VALUE (WORKING + TEST SET, NO CUTOFF) : 0.2050 REMARK 3 R VALUE (WORKING SET, NO CUTOFF) : 0.2040 REMARK 3 FREE R VALUE (NO CUTOFF) : 0.247 REMARK 3 FREE R VALUE TEST SET SIZE (%, NO CUTOFF) : 10.10 REMARK 3 FREE R VALUE TEST SET COUNT (NO CUTOFF) : 6010 REMARK 3 TOTAL NUMBER OF REFLECTIONS (NO CUTOFF) : 58133 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 6160 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 0 REMARK 3 SOLVENT ATOMS : 688 REMARK 3 REMARK 3 WILSON B VALUE (FROM FCALC, A**2) : 34.880 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. RMS WEIGHT COUNT REMARK 3 BOND LENGTHS (A) : 0.010 ; 0.020 ; 6259 REMARK 3 BOND ANGLES (DEGREES) : 1.300 ; 3.000 ; 8454 REMARK 3 TORSION ANGLES (DEGREES) : 24.660; 15.000; 3745 REMARK 3 PSEUDOROTATION ANGLES (DEGREES) : NULL ; NULL ; NULL REMARK 3 TRIGONAL CARBON PLANES (A) : 0.007 ; 0.020 ; 174 REMARK 3 GENERAL PLANES (A) : 0.007 ; 0.020 ; 919 REMARK 3 ISOTROPIC THERMAL FACTORS (A**2) : 4.650 ; 0.200 ; 6244 REMARK 3 NON-BONDED CONTACTS (A) : 0.027 ; 0.100 ; 86 REMARK 3 REMARK 3 INCORRECT CHIRAL-CENTERS (COUNT) : NULL REMARK 3 REMARK 3 BULK SOLVENT MODELING. REMARK 3 METHOD USED : TNT REMARK 3 KSOL : 0.69 REMARK 3 BSOL : 225.3 REMARK 3 REMARK 3 RESTRAINT LIBRARIES. REMARK 3 STEREOCHEMISTRY : TNT_DATA:CSDX_PROTGEO.DAT REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 1BQD COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY BNL. REMARK 100 THE DEPOSITION ID IS D_1000172000. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : JUL-96 REMARK 200 TEMPERATURE (KELVIN) : 290 REMARK 200 PH : 7.5 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : N REMARK 200 RADIATION SOURCE : ROTATING ANODE REMARK 200 BEAMLINE : NULL REMARK 200 X-RAY GENERATOR MODEL : ELLIOTT REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.5418 REMARK 200 MONOCHROMATOR : MONOCHROMATOR REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : IMAGE PLATE REMARK 200 DETECTOR MANUFACTURER : MAR SCANNER 300 MM PLATE REMARK 200 INTENSITY-INTEGRATION SOFTWARE : XDS REMARK 200 DATA SCALING SOFTWARE : AGROVATA REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 58133 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.100 REMARK 200 RESOLUTION RANGE LOW (A) : 20.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 0.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 91.3 REMARK 200 DATA REDUNDANCY : 2.600 REMARK 200 R MERGE (I) : 0.06500 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 10.1000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.10 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.15 REMARK 200 COMPLETENESS FOR SHELL (%) : 88.3 REMARK 200 DATA REDUNDANCY IN SHELL : 2.60 REMARK 200 R MERGE FOR SHELL (I) : 0.28000 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : 3.200 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: NULL REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: AMORE REMARK 200 STARTING MODEL: PDB ENTRY 1BQA REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 59.70 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 3.05 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: PH 7.5 REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 1 21 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 1.000000 0.000000 39.94000 REMARK 290 SMTRY3 2 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 6270 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 29580 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -21.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS IN SAME ASYMMETRIC UNIT REMARK 500 REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT. REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI DISTANCE REMARK 500 O HOH A 764 O HOH A 772 2.15 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 PRO A 13 -165.68 -71.02 REMARK 500 PRO A 16 -47.86 -12.91 REMARK 500 ALA A 26 32.77 -61.60 REMARK 500 THR A 47 76.50 -113.54 REMARK 500 TYR A 160 -54.79 -147.53 REMARK 500 ALA A 163 -3.92 -59.49 REMARK 500 ALA A 229 -62.20 -93.92 REMARK 500 ARG A 266 74.48 51.76 REMARK 500 ASN A 294 -76.20 -104.97 REMARK 500 SER A 296 -62.29 80.54 REMARK 500 HIS A 301 -74.75 -38.37 REMARK 500 LYS A 344 1.50 -63.52 REMARK 500 PRO B 16 -44.56 -28.44 REMARK 500 ALA B 26 13.83 -64.17 REMARK 500 TYR B 160 -57.46 -144.35 REMARK 500 ALA B 229 -67.18 -90.74 REMARK 500 LEU B 262 32.62 -99.58 REMARK 500 ARG B 266 76.27 51.08 REMARK 500 ASN B 294 -81.82 -103.61 REMARK 500 SER B 296 -64.42 80.13 REMARK 500 HIS B 301 -73.90 -35.47 REMARK 500 SER B 351 -19.34 -48.12 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: ACT REMARK 800 EVIDENCE_CODE: UNKNOWN REMARK 800 SITE_DESCRIPTION: ACTIVE SITE OF SUBUNIT A REMARK 800 REMARK 800 SITE_IDENTIFIER: BCT REMARK 800 EVIDENCE_CODE: UNKNOWN REMARK 800 SITE_DESCRIPTION: ACTIVE SITE OF SUBUNIT B DBREF 1BQD A 5 409 UNP P00509 AAT_ECOLI 1 396 DBREF 1BQD B 5 409 UNP P00509 AAT_ECOLI 1 396 SEQADV 1BQD ALA A 138 UNP P00509 PRO 128 ENGINEERED MUTATION SEQADV 1BQD ALA A 195 UNP P00509 PRO 184 ENGINEERED MUTATION SEQADV 1BQD LLP A 258 UNP P00509 LYS 246 MODIFIED RESIDUE SEQADV 1BQD ALA B 138 UNP P00509 PRO 128 ENGINEERED MUTATION SEQADV 1BQD ALA B 195 UNP P00509 PRO 184 ENGINEERED MUTATION SEQADV 1BQD LLP B 258 UNP P00509 LYS 246 MODIFIED RESIDUE SEQRES 1 A 396 MET PHE GLU ASN ILE THR ALA ALA PRO ALA ASP PRO ILE SEQRES 2 A 396 LEU GLY LEU ALA ASP LEU PHE ARG ALA ASP GLU ARG PRO SEQRES 3 A 396 GLY LYS ILE ASN LEU GLY ILE GLY VAL TYR LYS ASP GLU SEQRES 4 A 396 THR GLY LYS THR PRO VAL LEU THR SER VAL LYS LYS ALA SEQRES 5 A 396 GLU GLN TYR LEU LEU GLU ASN GLU THR THR LYS ASN TYR SEQRES 6 A 396 LEU GLY ILE ASP GLY ILE PRO GLU PHE GLY ARG CYS THR SEQRES 7 A 396 GLN GLU LEU LEU PHE GLY LYS GLY SER ALA LEU ILE ASN SEQRES 8 A 396 ASP LYS ARG ALA ARG THR ALA GLN THR PRO GLY GLY THR SEQRES 9 A 396 GLY ALA LEU ARG VAL ALA ALA ASP PHE LEU ALA LYS ASN SEQRES 10 A 396 THR SER VAL LYS ARG VAL TRP VAL SER ASN ALA SER TRP SEQRES 11 A 396 PRO ASN HIS LYS SER VAL PHE ASN SER ALA GLY LEU GLU SEQRES 12 A 396 VAL ARG GLU TYR ALA TYR TYR ASP ALA GLU ASN HIS THR SEQRES 13 A 396 LEU ASP PHE ASP ALA LEU ILE ASN SER LEU ASN GLU ALA SEQRES 14 A 396 GLN ALA GLY ASP VAL VAL LEU PHE HIS GLY CYS CYS HIS SEQRES 15 A 396 ASN ALA THR GLY ILE ASP PRO THR LEU GLU GLN TRP GLN SEQRES 16 A 396 THR LEU ALA GLN LEU SER VAL GLU LYS GLY TRP LEU PRO SEQRES 17 A 396 LEU PHE ASP PHE ALA TYR GLN GLY PHE ALA ARG GLY LEU SEQRES 18 A 396 GLU GLU ASP ALA GLU GLY LEU ARG ALA PHE ALA ALA MET SEQRES 19 A 396 HIS LYS GLU LEU ILE VAL ALA SER SER TYR SER LLP ASN SEQRES 20 A 396 PHE GLY LEU TYR ASN GLU ARG VAL GLY ALA CYS THR LEU SEQRES 21 A 396 VAL ALA ALA ASP SER GLU THR VAL ASP ARG ALA PHE SER SEQRES 22 A 396 GLN MET LYS ALA ALA ILE ARG ALA ASN TYR SER ASN PRO SEQRES 23 A 396 PRO ALA HIS GLY ALA SER VAL VAL ALA THR ILE LEU SER SEQRES 24 A 396 ASN ASP ALA LEU ARG ALA ILE TRP GLU GLN GLU LEU THR SEQRES 25 A 396 ASP MET ARG GLN ARG ILE GLN ARG MET ARG GLN LEU PHE SEQRES 26 A 396 VAL ASN THR LEU GLN GLU LYS GLY ALA ASN ARG ASP PHE SEQRES 27 A 396 SER PHE ILE ILE LYS GLN ASN GLY MET PHE SER PHE SER SEQRES 28 A 396 GLY LEU THR LYS GLU GLN VAL LEU ARG LEU ARG GLU GLU SEQRES 29 A 396 PHE GLY VAL TYR ALA VAL ALA SER GLY ARG VAL ASN VAL SEQRES 30 A 396 ALA GLY MET THR PRO ASP ASN MET ALA PRO LEU CYS GLU SEQRES 31 A 396 ALA ILE VAL ALA VAL LEU SEQRES 1 B 396 MET PHE GLU ASN ILE THR ALA ALA PRO ALA ASP PRO ILE SEQRES 2 B 396 LEU GLY LEU ALA ASP LEU PHE ARG ALA ASP GLU ARG PRO SEQRES 3 B 396 GLY LYS ILE ASN LEU GLY ILE GLY VAL TYR LYS ASP GLU SEQRES 4 B 396 THR GLY LYS THR PRO VAL LEU THR SER VAL LYS LYS ALA SEQRES 5 B 396 GLU GLN TYR LEU LEU GLU ASN GLU THR THR LYS ASN TYR SEQRES 6 B 396 LEU GLY ILE ASP GLY ILE PRO GLU PHE GLY ARG CYS THR SEQRES 7 B 396 GLN GLU LEU LEU PHE GLY LYS GLY SER ALA LEU ILE ASN SEQRES 8 B 396 ASP LYS ARG ALA ARG THR ALA GLN THR PRO GLY GLY THR SEQRES 9 B 396 GLY ALA LEU ARG VAL ALA ALA ASP PHE LEU ALA LYS ASN SEQRES 10 B 396 THR SER VAL LYS ARG VAL TRP VAL SER ASN ALA SER TRP SEQRES 11 B 396 PRO ASN HIS LYS SER VAL PHE ASN SER ALA GLY LEU GLU SEQRES 12 B 396 VAL ARG GLU TYR ALA TYR TYR ASP ALA GLU ASN HIS THR SEQRES 13 B 396 LEU ASP PHE ASP ALA LEU ILE ASN SER LEU ASN GLU ALA SEQRES 14 B 396 GLN ALA GLY ASP VAL VAL LEU PHE HIS GLY CYS CYS HIS SEQRES 15 B 396 ASN ALA THR GLY ILE ASP PRO THR LEU GLU GLN TRP GLN SEQRES 16 B 396 THR LEU ALA GLN LEU SER VAL GLU LYS GLY TRP LEU PRO SEQRES 17 B 396 LEU PHE ASP PHE ALA TYR GLN GLY PHE ALA ARG GLY LEU SEQRES 18 B 396 GLU GLU ASP ALA GLU GLY LEU ARG ALA PHE ALA ALA MET SEQRES 19 B 396 HIS LYS GLU LEU ILE VAL ALA SER SER TYR SER LLP ASN SEQRES 20 B 396 PHE GLY LEU TYR ASN GLU ARG VAL GLY ALA CYS THR LEU SEQRES 21 B 396 VAL ALA ALA ASP SER GLU THR VAL ASP ARG ALA PHE SER SEQRES 22 B 396 GLN MET LYS ALA ALA ILE ARG ALA ASN TYR SER ASN PRO SEQRES 23 B 396 PRO ALA HIS GLY ALA SER VAL VAL ALA THR ILE LEU SER SEQRES 24 B 396 ASN ASP ALA LEU ARG ALA ILE TRP GLU GLN GLU LEU THR SEQRES 25 B 396 ASP MET ARG GLN ARG ILE GLN ARG MET ARG GLN LEU PHE SEQRES 26 B 396 VAL ASN THR LEU GLN GLU LYS GLY ALA ASN ARG ASP PHE SEQRES 27 B 396 SER PHE ILE ILE LYS GLN ASN GLY MET PHE SER PHE SER SEQRES 28 B 396 GLY LEU THR LYS GLU GLN VAL LEU ARG LEU ARG GLU GLU SEQRES 29 B 396 PHE GLY VAL TYR ALA VAL ALA SER GLY ARG VAL ASN VAL SEQRES 30 B 396 ALA GLY MET THR PRO ASP ASN MET ALA PRO LEU CYS GLU SEQRES 31 B 396 ALA ILE VAL ALA VAL LEU MODRES 1BQD LLP A 258 LYS MODRES 1BQD LLP B 258 LYS HET LLP A 258 24 HET LLP B 258 24 HETNAM LLP (2S)-2-AMINO-6-[[3-HYDROXY-2-METHYL-5- HETNAM 2 LLP (PHOSPHONOOXYMETHYL)PYRIDIN-4- HETNAM 3 LLP YL]METHYLIDENEAMINO]HEXANOIC ACID HETSYN LLP N'-PYRIDOXYL-LYSINE-5'-MONOPHOSPHATE FORMUL 1 LLP 2(C14 H22 N3 O7 P) FORMUL 3 HOH *688(H2 O) HELIX 1 1 PRO A 16 ARG A 25 1 10 HELIX 2 2 THR A 51 ASN A 63 1 13 HELIX 3 3 PRO A 77 PHE A 88 1 12 HELIX 4 4 ALA A 93 ASN A 96 1 4 HELIX 5 5 GLY A 107 ASN A 122 1 16 HELIX 6 6 PRO A 141 ALA A 150 5 10 HELIX 7 7 PHE A 170 GLU A 179 1 10 HELIX 8 8 LEU A 202 LYS A 215 1 14 HELIX 9 9 GLU A 235 ALA A 244 5 10 HELIX 10 10 TYR A 263 GLU A 265 5 3 HELIX 11 11 SER A 277 ARG A 292 1 16 HELIX 12 12 ALA A 300 SER A 311 1 12 HELIX 13 13 ASP A 313 GLU A 343 1 31 HELIX 14 14 SER A 351 LYS A 355 5 5 HELIX 15 15 LYS A 367 PHE A 377 1 11 HELIX 16 16 VAL A 389 GLY A 391 5 3 HELIX 17 17 MET A 397 VAL A 405 1 9 HELIX 18 18 PRO B 16 ARG B 25 1 10 HELIX 19 19 THR B 51 ASN B 63 1 13 HELIX 20 20 PRO B 77 PHE B 88 1 12 HELIX 21 21 ALA B 93 ASN B 96 1 4 HELIX 22 22 GLY B 107 ASN B 122 1 16 HELIX 23 23 PRO B 141 ALA B 150 5 10 HELIX 24 24 PHE B 170 GLU B 179 1 10 HELIX 25 25 LEU B 202 LYS B 215 1 14 HELIX 26 26 GLU B 235 ALA B 244 5 10 HELIX 27 27 TYR B 263 GLU B 265 5 3 HELIX 28 28 SER B 277 ARG B 292 1 16 HELIX 29 29 ALA B 300 LEU B 310 1 11 HELIX 30 30 ASP B 313 GLU B 343 1 31 HELIX 31 31 SER B 351 LYS B 355 5 5 HELIX 32 32 LYS B 367 PHE B 377 1 11 HELIX 33 33 VAL B 389 GLY B 391 5 3 HELIX 34 34 MET B 397 ALA B 407 1 10 SHEET 1 A 5 ALA A 100 PRO A 106 0 SHEET 2 A 5 VAL A 267 VAL A 273 -1 N LEU A 272 O ARG A 101 SHEET 3 A 5 LEU A 250 SER A 255 -1 N SER A 254 O ALA A 269 SHEET 4 A 5 LEU A 218 PHE A 223 1 N PHE A 221 O ILE A 251 SHEET 5 A 5 VAL A 185 HIS A 189 1 N VAL A 186 O LEU A 218 SHEET 1 B 2 ARG A 129 ASN A 137 0 SHEET 2 B 2 GLU A 154 ALA A 159 1 N GLU A 154 O VAL A 133 SHEET 1 C 2 PHE A 360 PHE A 362 0 SHEET 2 C 2 ARG A 386 ASN A 388 -1 N VAL A 387 O SER A 361 SHEET 1 D 5 ALA B 100 PRO B 106 0 SHEET 2 D 5 VAL B 267 VAL B 273 -1 N LEU B 272 O ARG B 101 SHEET 3 D 5 LEU B 250 SER B 255 -1 N SER B 254 O ALA B 269 SHEET 4 D 5 LEU B 218 PHE B 223 1 N PHE B 221 O ILE B 251 SHEET 5 D 5 VAL B 185 HIS B 189 1 N VAL B 186 O LEU B 218 SHEET 1 E 2 ARG B 129 ASN B 137 0 SHEET 2 E 2 GLU B 154 ALA B 159 1 N GLU B 154 O VAL B 133 SHEET 1 F 2 PHE B 360 PHE B 362 0 SHEET 2 F 2 ARG B 386 ASN B 388 -1 N VAL B 387 O SER B 361 LINK C SER A 257 N LLP A 258 1555 1555 1.33 LINK C LLP A 258 N ASN A 259 1555 1555 1.33 LINK C SER B 257 N LLP B 258 1555 1555 1.32 LINK C LLP B 258 N ASN B 259 1555 1555 1.33 CISPEP 1 ASN A 194 ALA A 195 0 3.88 CISPEP 2 ASN B 194 ALA B 195 0 3.83 SITE 1 ACT 23 ASP A 15 ILE A 17 LEU A 18 ILE A 37 SITE 2 ACT 23 GLY A 38 VAL A 39 TYR B 70 GLY A 107 SITE 3 ACT 23 GLY A 108 THR A 109 TRP A 140 ASN A 194 SITE 4 ACT 23 ASP A 222 ALA A 224 TYR A 225 SER A 255 SITE 5 ACT 23 LLP A 258 ARG A 266 ARG B 292 SER B 296 SITE 6 ACT 23 ASN B 297 PHE A 360 ARG A 386 SITE 1 BCT 23 ASP B 15 ILE B 17 LEU B 18 ILE B 37 SITE 2 BCT 23 GLY B 38 VAL B 39 TYR A 70 GLY B 107 SITE 3 BCT 23 GLY B 108 THR B 109 TRP B 140 ASN B 194 SITE 4 BCT 23 ASP B 222 ALA B 224 TYR B 225 SER B 255 SITE 5 BCT 23 LLP B 258 ARG B 266 ARG A 292 SER A 296 SITE 6 BCT 23 ASN A 297 PHE B 360 ARG B 386 CRYST1 88.490 79.880 89.680 90.00 119.58 90.00 P 1 21 1 4 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.011301 0.000000 0.006414 0.00000 SCALE2 0.000000 0.012519 0.000000 0.00000 SCALE3 0.000000 0.000000 0.012822 0.00000 MTRIX1 1 -1.000000 0.000080 -0.000390 44.24355 1 MTRIX2 1 -0.000080 -1.000000 0.000540 0.00007 1 MTRIX3 1 -0.000390 0.000540 1.000000 0.00416 1